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Abstract
Bone mineral density (BMD) is a strong predictor of osteoporotic fracture. It is also one of
the most heritable disease-associated quantitative traits. As a result, there has been consid-
erable effort focused on dissecting its genetic basis. Here, we performed a genome-wide
association study (GWAS) in a panel of inbred strains to identify associations influencing
BMD. This analysis identified a significant (P = 3.1 x 10−12) BMD locus on Chromosome
3@52.5 Mbp that replicated in two separate inbred strain panels and overlapped a BMD
quantitative trait locus (QTL) previously identified in a F2 intercross. The association
mapped to a 300 Kbp region containing four genes; Gm2447, Gm20750, Cog6, and Lhfp.
Further analysis found that Lipoma HMGIC Fusion Partner (Lhfp) was highly expressed in
bone and osteoblasts. Furthermore, its expression was regulated by a local expression QTL
(eQTL), which overlapped the BMD association. A co-expression network analysis revealed
that Lhfp was strongly connected to genes involved in osteoblast differentiation. To directly
evaluate its role in bone, Lhfp deficient mice (Lhfp-/-) were created using CRISPR/Cas9.
Consistent with genetic and network predictions, bone marrow stromal cells (BMSCs) from
Lhfp-/- mice displayed increased osteogenic differentiation. Lhfp-/- mice also had elevated
BMD due to increased cortical bone mass. Lastly, we identified SNPs in human LHFP that
were associated (P = 1.2 x 10−5) with heel BMD. In conclusion, we used GWAS and systems
genetics to identify Lhfp as a regulator of osteoblast activity and bone mass.
Author summary
Osteoporosis is a common, chronic disease characterized by low bone mineral density
(BMD) that puts millions of Americans at high risk of fracture. Variation in BMD in the
general population is, in large part, determined by genetic factors. To identify novel genes
influencing BMD, we performed a genome-wide association study in a panel of inbred
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mouse strains. We identified a locus on Chromosome 3 strongly associated with BMD.
Using a combination of systems genetics approaches, we connected the expression of the
Lhfp gene with BMD-associated genetic variants and predicted it influenced BMD by
altering the activity of bone-forming osteoblasts. Using mice deficient in Lhfp, we demon-
strated that Lhfp negatively regulates bone formation and BMD. These data suggest that
inhibiting Lhfp may represent a novel therapeutic strategy to increase BMD and decrease
the risk of fracture.
Introduction
It is currently estimated that half of all Americans over the age of 50 already have or are at high
risk of developing osteoporosis [1]. Bone mineral density (BMD) is used clinically to diagnose
osteoporosis and beyond age, it is the single strongest predictor of the risk of fracture [2].
BMD is also one of the most heritable disease-associated quantitative traits with studies dem-
onstrating that up to 80% of the variance in peak bone mass is heritable [3–6]. Consistent with
its high heritability, genome-wide association studies (GWASs) in humans have identified
hundreds of loci for BMD [7–9]. However, only a small fraction of the variance in BMD can
be collectively explained by these loci, suggesting that BMD is influenced by a large number of
small effect size loci [10]. As a result, there remains much to be discovered regarding the genet-
ics of bone mass and genetic mapping efforts using mouse models is a complementary
approach to identify novel regulators of bone mass [11–13].
Historically, linkage analyses in intercrosses, backcrosses, and recombinant inbred strain
panels were the mainstay of mouse genetics [14]. These approaches were used to identify doz-
ens of quantitative trait loci (QTL) for BMD and other bone traits [15,16]. However, identify-
ing causative genes underlying QTL proved challenging [17]. Over the last decade, gene
mapping approaches have transitioned from low-resolution linkage mapping to high-resolu-
tion GWASs [11]. The first GWASs in mice used panels of inbred mouse strains [18–21] and
by leveraging accumulated recombinations, this approach significantly increased mapping res-
olution [19]. However, the approach was limited by population structure and low statistical
power, due to the complicated breeding histories of inbred mouse strains and the small num-
ber of easily accessible and appropriate inbred strains (N typically < 30), respectively. Later
studies demonstrated that these issues could be partly addressed by accounting for population
structure and leveraging information from linkage-based QTL studies [22,23]. Given the sig-
nificant amount of existing phenotypic and genotypic data on inbred strain panels [24], this
approach is potentially a cost-effective strategy to identify novel regulators of complex traits.
High-resolution mapping approaches have significantly increased our ability to identify
narrow regions of the genome harboring trait associated genetic variants. It is still, however, a
challenge to identify causal genes and several approaches have been developed that can assist
in bridging this gap. Specifically, systems genetics approaches involving the integration of
other types of “-omics” data have proven useful [25]. Two systems genetics approaches for
informing GWAS are expression quantitative trait loci (eQTL) discovery and co-expression
network analysis [26]. EQTL discovery allows one to link variants associated with a trait, such
as BMD, to changes in gene expression which leads to the hypothesis that the change in gene
expression is causal for the change in phenotype. EQTL studies have been tremendously suc-
cessful in identifying target genes downstream of genome-wide significant variants (as exam-
ples; [27,28]). However, in many cases the identified target genes have no known connection
to the phenotype under investigation. It has been shown that co-expressed genes often operate
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in the same pathway or are functionally related [29]. Therefore, by using co-expression net-
works, which cluster genes based on patterns of co-expression across a series of perturbations
[30], it is possible to develop hypotheses as to the function of a novel gene. When a locus has
been resolved down to a small number of genes using genetic methods, unknown or poorly
characterized genes can be ranked as the most likely candidate based on their function pre-
dicted from a co-expression network generated in a disease relevant tissue or cell-type [12,31].
Here, we used GWAS in an inbred strain panel to identify two chromosomal regions har-
boring variants influencing BMD. One of the associations, located on Chromosome (Chr.) 3,
affected BMD in both sexes and was replicated in two separate inbred strain panels and an F2
intercross. This locus mapped to a 300 Kbp interval (NCBI37/mm9; Chr3:52.5–52.8 Mbp)
encompassing four genes, Gm2447, Gm20750, Cog6, and Lhfp. An eQTL analysis and exami-
nation of a bone co-expression network suggested that Lhfp was a causal gene at this locus.
The analysis of BMD, and other bone parameters, in Lhfp mutant mice supported this hypoth-
esis. Additionally, SNPs within human LHFP were associated with heel BMD. Thus, we have
used GWAS and systems genetics to identify Lhfp as a novel regulator of bone mass.
Results
Identification of genome-wide associations for BMD
We performed a GWAS for total body BMD in 26 classical (non wild-derived) inbred strains
at 12 months of age fed a chow diet. Genome scans were performed separately for each sex
using the Efficient Mixed Model Algorithm (EMMA) to account for population stratification
(S1 and S2 Files). In female mice, a significant (permutation determined threshold of -log10
(P)>6) association was identified on Chromosome (Chr.) 3 and, in males, significant (permu-
tation determined threshold of -log10(P)>5.9) loci were identified on Chrs. 2 and 3 (Fig 1).
Replication of the Chr. 3 association
Given our goal of identifying novel genes influencing BMD, we selected the Chr. 3 locus for
further investigation. This locus was chosen because it was the most significant and the only
one identified in both sexes (Fig 1). However, upon closer inspection, Chr. 3 harbored two
associations, with peaks at 52.5 and 63.3 Mbp. In males, the 52.5 Mbp peak was the most sig-
nificant (-log10(P) = 11.5), whereas in females the 63.3 Mbp peak was the most significant
(-log10(P) = 5.9). The lead SNPs at both peaks were in moderate linkage disequilibrium (r2 =
0.46), making it unclear if they represented independent loci. We performed conditional anal-
yses in males and in both cases each peak still exceeded chromosome-wise significance (-log10
(P)>2.9) after controlling for the other, suggesting they represent independent loci.
We next sought to identify independent datasets supporting the validity of the Chr. 3 asso-
ciations. There were 17 lead SNPs (the B6 reference allele was the minor allele at all SNPs with
a frequency of 0.42), with the exact same strain distribution pattern (SDP) (S3 File), at the
Chr.3@52.5 Mbp association. All 16 were polymorphic between B6 and C3H. We previously
identified a QTL, Bmd40, affecting femoral BMD on Chr. 3 in 32 week-old mice from a
C57BL/6J (B6) x C3H/HeJ (C3H) (BXH) F2 intercross fed a high-fat diet [16]. The peak of
Bmd40 overlaps both associations (Fig 2A). We also identified two sets of inbred strains with
BMD measurements (the “Naggert” and “Tordoff” studies; data available from the Mouse Phe-
nome Database [32] (https://phenome.jax.org/)) that were large enough (N strains > 25) to
attempt to replicate the associations. In both “Naggert” and “Tordoff” panels, the strains used
largely overlapped, but they did represent independent measures of BMD at different ages and
conditions (Naggert—15–17 wks old, high-fat diet; Tordoff—14–18 weeks, chow diet). In both
strain sets the exact same sets of SNPs at 52.5 Mbp reached chromosome-wide significance
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(-log10(P)>2.9) in both sexes (Naggert males -logP = 3.03, Naggert females -logP = 3.09, Tord-
off males -log10P = 7.73, and Tordoff females -log10P = 5.17) (Fig 2B–2E). The association at
63.3 Mbp replicated in the Tordoff cohort (male -log10P = 3.18 and female -log10P = 2.92),
but not in the Naggert cohort (male -log10P = 1.15 and female -log10P = 1.09) (Fig 2B–2E).
These data provide additional support for the BMD association at 52.5 Mbp. Importantly, in
all three inbred strain panels (“Ackert”, “Naggert” and “Tordoff”) and the BXH F2 intercross,
reference (B6) alleles were associated with increased BMD relative to non-reference (C3H)
alleles (Fig 2F–2I). Together, these data, from independent sources, are consistent with the
hypothesis that a variant(s) in proximity of 52.5 Mbp on Chr. 3 influences BMD.
The Chr. 3 association implicates a 300 Kbp interval encompassing four
transcripts
The set of SNPs that were the most significantly associated with BMD spanned a 300 Kbp
interval from 52.5 to 52.8 Mbp (Fig 3A and 3B). This region contained four RefSeq transcripts:
Gm2447, Gm20750, Cog6, and the 5’ end of Lhfp. Gm2447 and Gm20750 were listed as “pre-
dicted” RefSeq transcripts and annotated as long non-coding RNAs (lncRNAs). The evidence
for these transcripts was based on prediction models and a small number of expressed
sequence tag (EST) sequences. Neither of these transcripts have homologs in humans, rats, or
any other mammalian species. To determine if Gm2447 and Gm20750 were expressed in
Fig 1. Manhattan plot for BMD GWAS in the “Ackert” inbred strain panel. A) GWAS results in male mice. B) GWAS results in female mice. Data from 27 classical
inbred strains was used in the GWAS.
https://doi.org/10.1371/journal.pgen.1008123.g001
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mouse bone or bone cells, we performed total RNA-seq (poly A+ and poly A-) on three bone
and three marrow-derived osteoblasts samples. Gm2447 and Gm20750 were not expressed,
whereas the other two transcripts, Cog6 and Lhfp, which are well-annotated protein-coding
sequences, were highly expressed in both bone (Fig 3C) and osteoblasts (Fig 3D). We also ana-
lyzed the expression profiles of Cog6 and Lhfp in 96 mouse tissues and cell lines using data
available from BioGPS (http://biogps.org/) [33]. Cog6 was highly expressed in all tissues pro-
filed (Fig 3E). Lhfp showed a more restrictive expression profile (Fig 3E). Importantly, Lhfp
expression in primary calvarial osteoblasts was among the highest of any of the 96 samples sur-
veyed (Fig 3E). Cog6 is part of the conserved oligomeric Golgi complex required for maintain-
ing normal structure and activity of the Golgi apparatus [34]. Lhfp is a member of the lipoma
Fig 2. Replication of BMD association on Chr. 3@52.5 Mbp in both sexes in multiple independent populations. A) Bmd40, a QTL impacting BMD in an F2 cross
between C57BL/6J and C3H/HeJ, overlaps the Chr. 3 association at 52.5 Mbp. Replication of the Chr. 3 association at 52.5 Mbp in the “Naggert” (N = 31), males (B) and
females (C), and “Tordoff” (N = 30), males (D) and females (E), inbred strain panels. Chromosome-wide significance was -logP>2.9 in both strain sets. Non-ref (C3H/
HeJ) alleles of associated SNPs increase BMD in the “Ackert” (F), “Tordoff1” (G), and “Naggert1” (H) strain panels and the BXH F2 intercross (I).
https://doi.org/10.1371/journal.pgen.1008123.g002
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Fig 3. Interrogation of the Chr. 3@52.5 Mbp association. The association implicates four genes (Gm2447, Gm20750, Cog6 and Lhfp) based on their location with the
locus in males (A) and females (B). RNA-seq expression profiles of the four genes in mouse bone (C) and osteoblasts (D) derived from bone marrow stromal cells (N = 3
each sample type). E) Microarray expression profiles for Cog6 and Lhfp in 96 diverse mouse tissues and cell-types (data from BioGPS, http://biogps.org/) [33].
https://doi.org/10.1371/journal.pgen.1008123.g003
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HMGIC fusion partner (LHFP) gene family with no known function [35]. All other transcripts
on either side of the region were >200 Kbp away.
Coding polymorphisms in Cog6 and Lhfp
We cannot exclude Gm2447 and Gm20750 (or for that matter other genes flanking the associa-
tion); however, based on the data above we focused on interrogating Cog6 or Lhfp as potential
causal genes. First, we evaluated Cog6 and Lhfp for coding polymorphisms among inbred
strains. Based on whole genome-sequence data from C57BL6/J and C3H/HeJ (which carry
alternative alleles at the association) there are no coding variants between the strains for Lhfp
[36]. In contrast, there were three non-synonymous SNPs in Cog6 between B6 and C3H.
These SNPs resulted in (rs30302002) I461V, (rs30323949) V620I and (rs30323946) S643N
amino acid substitutions. However, using PolyPhen2, SIFT, and PROVEAN all three substitu-
tions were predicted to be benign/tolerated and not impact Cog6 function [37–39].
Lhfp is regulated by a local eQTL in liver
We next determined if the same SNPs associated with BMD regulated the expression of Lhfp
or Cog6 (or any gene ± 1Mbp of the association). We searched for local expression quantitative
trait loci (eQTL) using expression data in liver, brain, adipose and muscle tissues in the BXH
F2 intercross. Although expression data on bone or bone cells would have been ideal for this
analysis, these data were not available. This did, however, allow us to identify local eQTL that
might also be operative in bone. We observed a highly significant local eQTL for Lhfp
(LOD = 19.9) in liver (Fig 4A). Cog6 and all other genes in proximity of the region were not
regulated by a local eQTL in any tissue (max cis eQTL LOD = 1.8 across all four tissues). The
lead Lhfp eQTL SNP (rs3665395) was located in the first intron of Lhfp and B6 alleles of
rs3665395 were associated with increased expression of Lhfp relative to C3H alleles (Fig 4B).
In liver, we observed a negative correlation (r = -0.29, P = 1.5 x 10−4) between Lhfp and BMD,
as would be expected given that B6 alleles of rs3665395 were associated with decreased BMD
and increased Lhfp (Fig 4C). We also searched for local eQTL using expression data from
bone in the Hybrid Mouse Diversity Panel (HMDP) panel, but did not identify local eQTL for
either Cog6 or Lhfp.
Network analysis predicts a role for Lhfp in the regulation of osteoblast
activity
Our group and others [12,27,31,40] have shown that co-expression network analysis can iden-
tify interactions among genes and knowledge of these interactions can assist in predicting
gene function and/or the cell type in which a gene is operative. Therefore, we next used a bone
co-expression network to further evaluate Lhfp and Cog6. For the analysis we used a previously
generated whole bone (femur with marrow removed) co-expression network from the Hybrid
Mouse Diversity Panel (HMDP) that consisted of 13,759 genes partitioned into 21 co-expres-
sion modules [41,42]. In this network, Lhfp was a member of module 9 and Cog6 was a mem-
ber of module 2. Module 2 was enriched in a large number of gene ontology terms including
“mitochondrion”, “oxidative phosphorylation” and “actin cytoskeleton”; all of which are
important to bone. However, module 2 did not have a signature of a particular bone cell-type,
nor was it enriched for genes known to influence BMD. In contrast, we have previously dem-
onstrated that module 9 is enriched for genes 1) directly involved in osteoblast differentiation,
2) implicated by BMD GWAS, and 3) when knocked-out in mice impact BMD [31,42].
To investigate specific network connections for Lhfp and Cog6, we identified the 150 genes-
most strongly connected to each gene in their respective module (S4 and S5 Files). The genes
Lhfp is a genetic determinant of BMD
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with the strongest connections to Cog6 were enriched for genes involved in “muscle structure
development” (FDR = 2.9 x 10−10), “muscle cell development” (FDR = 4.4 x 10−10), among
many other similar muscle-related categories (S6 File). In contrast the genes with the strongest
connections to Lhfp were, similar to module 9, enriched for genes involved in “ossification”
(FDR = 1.5 x 10−7), “osteoblast differentiation” (FDR = 8.0 x 10−4), “skeletal system develop-
ment” (FDR = 6.4 x 10−3), “bone development” (FDR = 3.3 x 10−2), among many other related
bone-related functional categories (S7 File and Fig 5A). The Lhfp-centric network contained a
number of genes with key roles in osteoblast differentiation and activity, including Sp7, Pthr1,
Akp2, Tmem119, and Bmp3 (Fig 5B). Together, these data suggest that Lhfp is involved in the
activity of osteoblasts, a process of direct relevance to the regulation of bone mass.
Lhfp regulates the number and osteogenic differentiation of bone marrow
stromal cells
Bone marrow stromal cells (BMSCs) are adherent marrow cells that contain the mesenchymal
progenitors of osteoblasts [43]. To test the role of Lhfp in osteoblast function, we quantified
the number of BMSCs and their ability to form osteoblasts from mice lacking Lhfp. Using
CRISPR/Cas9, we created five small deletions (ranging from 4–16 bps) in exon 2 (ATG start
codon is in exon 2) of Lhfp (Table 1). All five were frameshift mutations resulting in a trun-
cated LHFP protein (S1 Fig). As expected, we observed significantly decreased Lhfp transcript
Fig 4. Lhfp expression is regulated by a local eQTL in liver overlapping the Chr.3@52.5 Mbp BMD association. A)
Strong local eQTL for Lhfp in liver tissue from BXH F2 mice. B) In BXH livers, C57BL6/J (B6) alleles at the Chr. 3 local
eQTL are associated with increased Lhfp expression. Data are presented as means ± s.e.m. C) Lhfp expression in liver is
negatively correlated with weight-adjusted femoral BMD in BXH F2 mice.
https://doi.org/10.1371/journal.pgen.1008123.g004
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levels in heterozygotes (Lhfp+/-) and mutants (Lhfp-/-) from all five lines (Fig 6A). Since all five
mutations impacted Lhfp expression in the same manner, we grouped littermate mice by geno-
type from all lines for all downstream experiments.
Next, we performed colony-forming unit-fibroblast (CFU-F) assays, a direct measure of
BMSCs, in 16 week-old Lhfp-/- and littermate Lhfp+/+ mice. We observed similar trends in both
sexes; therefore, all data were combined and adjusted for the effects of sex to increase power.
In Lhfp-/- mice, we observed a significant (P = 0.02) increase in CFU-F number (Fig 6B). We
next evaluated the ability of BMSCs from Lhfp+/+ and Lhfp-/- mice to differentiate into mineral-
izing osteoblasts. Consistent with network predictions, Lhfp-/- BMSCs exhibited increased
mineralization as measured by bound alizarin red (P = 0.02; Fig 6C).
Lhfp regulates cortical bone mass
We next determined if bone mass was altered in Lhfp mutant lines. To replicate the conditions
of the Ackert inbred strain panel and the BXH F2, we generated two cohorts of mice. The first
Fig 5. Lhfp in bone is highly connected to genes involved in osteoblast differentiation. A) Network depiction of gene ontology “biological process” categories
containing more of the genes with strong connections to Lhfp in a bone co-expression network than would be expected by chance. B) Genes with the strongest
connections to Lhfp in a bone co-expression network. The genes highlighted in green have been shown to be directly involved in osteoblast differentiation.
https://doi.org/10.1371/journal.pgen.1008123.g005
Table 1. Description of CRISPR/Cas9-induced Lhfp mutations.
Mutant mouse line Founder mouse Deletion Size Base pairs deleted Chr 3 Map position deleted (GRCm38.p4 C57BL/6J)
1 C 4 bp TGGG 53043620–530436623
2 B 4 & 3 bp
or 8 bp + T
CCTG & TGG
CCTGATGG + A inserted
53043615–530436618; 53043620–530436622
53043615–530436622
3 A 8 bp TGG GTT GC 53043620–530436627
4 B & C 11 bp CTG ATG GGT TG 53043616–530436626
5 A 16 bp TCA CTG CCC TGA TGG G 53043608–530436623
https://doi.org/10.1371/journal.pgen.1008123.t001
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was fed a chow diet for 12 months, while the second was fed a high-fat diet from 8 to 32 weeks
of age. Based on the negative correlation between BMD and Lhfp expression, the direction of
the genetic effects on expression in liver, and increased osteoblast activity observed above, we
Fig 6. Lhfp is a negative regulator of osteoblast differentiation and cortical bone mass. A) Lhfp transcript levels are decreased due to the five nonsense mutations
created using CRISPR/Cas9 (Lhfp+/+, N = 10; Lhfp+/-, N = 11; Lhfp-/-, N = 7; represents at least one mouse from each of the five mutant lines, see Table 1). Data are
presented as means ± 1.5 times interquartile range (IQR). The number of CFU-F colonies (B) and osteoblast mineralization (C) are increased in Lhfp-/- mice (Lhfp+/+,
N = 41; Lhfp-/-, N = 43). Data are presented as means ± s.e.m. Images are from the sample closest to the mean for each genotype. D-G) Femoral BMD, cortical bone area
fraction (BA/TA), cortical thickness (Ct.Th), and tissue mineral density (TMD) in Lhfp mutant mice in 32 week old mice fed a high-fat diet. Data are presented as
means ± 1.5 times IQR. H-K) Femoral BMD, cortical bone area fraction (BA/TA), cortical thickness (Ct.Th), and tissue mineral density (TMD) in Lhfp mutant mice in
52 week old mice fed a chow diet. Data are presented as means ± 1.5 times IQR.
https://doi.org/10.1371/journal.pgen.1008123.g006
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predicted increased BMD in Lhfp-/- mice. In both cohorts, BMD was measured in mice of all
three genotypes and cortical and trabecular microarchitecture was measured by microCT only
in Lhfp+/+ and Lhfp-/- mice. At 32 weeks of age in mice on a high-fat diet we observed signifi-
cantly (P = 2.6 x 10−3) increased femoral BMD as a function of mutant Lhfp alleles in females,
but not males (Fig 6D).
BMD is an inherently noisy phenotype; therefore, to generate a more detailed understand-
ing of the effects of Lhfp in bone we used microCT to investigate the amount of bone in both
the femoral trabecular and cortical compartments. We did not observe effects on trabecular
bone mass at the distal femur in either male or female mice. However, Lhfp-/- mice of both
sexes had significantly (P<0.05) increased femoral cortical bone area fraction (BA/TA) and
cortical thickness (Ct.Th) as compared to Lhfp+/+ littermates (Fig 6E and 6F). We also
observed a significant (P = 0.03) increase in tissue mineral density (TMD) in male Lhfp-/- mice
(Fig 6G). In general, we observed the same trends of increased cortical bone mass in Lhfp-/-
mice at 52 weeks of age; however, only Ct.Th in females was significant (P = 0.03) (Fig 6H–
6K). These data indicate that Lhfp is a negative regulator of cortical bone mass in both male
and female mice. They are also consistent with Lhfp underlying, at least in part, the BMD asso-
ciation on Chr. 3@52.5 Mbp.
Variants in human LHFP are associated with BMD
We next determined if the human region syntenic with the mouse BMD locus harbored SNPs
associated with variation in BMD. For this analysis we utilized data from the largest GWAS
performed to date (N~426K) for heel BMD [9]. Heel BMD has been demonstrated to be highly
genetically correlated with BMD at more clinically relevant sites such as the spine and femoral
neck [8,9]. The human region syntenic with the mouse Chr. 3@52.5 Mbp spanned from 39.9
to 40.6 Mbp on Chr. 13. This region harbored 4055 SNPs. A set of 14 SNPs were significantly
associated (P = 1.2 x 10−5) after adjusting for the total number of SNPs in the region (P<1.23 x
10−5) (Fig 7). These SNPs were located in intron 3 of LHFP. We queried eQTL for the Gene
Tissue Expression (GTEx) project [44], but there were no eQTL for any genes ± 1 Mbp of the
association that colocalized with the heel BMD association. Though these data do not directly
implicate LHFP, they do support its potential involvement in the regulation of human BMD.
Discussion
In this study, we used GWAS in a mouse inbred strain panel and a multifaceted systems genet-
ics approach to identify and validate a high-resolution association for BMD on Chr. 3. The
association directly implicated four genes: Gm2447, Gm20750, Cog6 and Lhfp. Of these, Lhfp
expression was regulated by a local eQTL in liver and was predicted, based on a bone gene co-
expression network, to be involved in osteoblast-mediated bone formation. We demonstrated
that mice deficient in Lhfp displayed increased BMSC number and increased BMSC osteogenic
differentiation. Furthermore, Lhfp-/- had increased BMD due to increased cortical bone mass.
Together these data strongly suggest that Lhfp is responsible, at least in part, for the BMD asso-
ciation we identified on Chr. 3@52.5 Mbp. This work defines Lhfp as a negative regulator of
the pool of osteoprogenitor cells, osteoblast activity, and cortical bone mass.
GWAS in mice has proven to be a powerful approach for the identification of genomic
regions harboring trait-associated genetic variation [11]. The earliest applications of GWAS in
mice used panels of readily accessible inbred strains [18–20]. However, such approaches were
plagued by false positives due to population stratification [22]. Aware of this limitation, we
first performed GWAS for BMD after correcting for population structure in inbred strains and
then replicated the analysis in two separate strain panels (containing many of the same strains,
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but representing independent measures of BMD in different environments) and an F2 inter-
cross. Of the multiple loci identified, the association on Chr. 3 at 52.5 Mbp was identified in all
datasets, strongly suggesting it represents a bona-fide genetic association.
The Chr. 3 locus, as defined by the interval harboring the most significant SNPs, contained
four genes; Gm2447, Gm20750, Cog6 and Lhfp. Gm2447 and Gm20750 were both predicted
lncRNAs. This prediction is based on limited data and the fact that we did not observe their
Fig 7. The human region syntenic to the mouse BMD locus harbors SNPs associated with heel BMD. LocusZoom plot of heel BMD-SNP associations in the human
genomic region (Chromosome 13 from 39.8 to 40.7 Mbp) syntenic to mouse Chromosome 3 from 52.5 to 52.8 Mbp.
https://doi.org/10.1371/journal.pgen.1008123.g007
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expression in bone tissue or osteoblasts (though we only measured their expression in one
inbred strain), suggest they are not likely causal for the locus; though, this alone is not enough
to definitely exclude their involvement. For Cog6 and Lhfp we used eQTL data and a bone co-
expression network to assist in evaluating their potential causality. Both analyses supported a
role for Lhfp. Using eQTL data from liver tissue in the BXH F2 intercross, we observed that
variants associated with decreased BMD were associated with increased expression of Lhfp.
We did not observe an association between the BMD-associated variants and Cog6 expression.
Furthermore, Lhfp was a member of a well-studied module of co-expressed genes in mouse
bone. This module is highly enriched for genes that play a role in osteoblast function, which
provides a direct explanation as to how Lhfp may be impacting BMD. In contrast, Cog6 was a
member of a module enriched for genes involved in a wide range of “energy-generating” func-
tions. Importantly, all of our experimental results confirmed that Lhfp is a negative regulator
of osteoblast activity and BMD. While these data support a role for Lhfp in the effects of the
Chr. 3 locus, they do not exclude any of the other genes in, as well as flanking the locus.
In all four genetic populations used to identify the association on Chr. 3@52.5 Mbp, the
strength of the association differed by sex. For example, in the “Ackert” population the associa-
tion was stronger in males relative to females. In the “Naggert” strain set the strength of the
association was similar in both sexes, albeit both were lower than seen in the other three popu-
lations. Similar to the “Ackert” strains, the association was stronger in males than females in
the “Tordoff” strain set. In the BXH F2, the Chr. 3 QTL was male-specific, with little to no sig-
nal in females. The increase in cortical bone mass in Lhfp-/- mice was also sexually dimorphic.
Although Lhfp deficiency increased cortical bone mass in both sexes in general, the effects
were slightly more pronounced in females than males. This discrepancy could be the result of
inaccuracies in estimating genetic effect sizes in the relatively small strain sets, the extent of
linkage in the F2 confounding the sex effects, or influences from the different genetic back-
grounds of the populations studied (strains sets vs. F2 vs. knockout).
Little is known regarding the molecular function of Lhfp. Lhfp is a member of the Lhfp-like
gene family, which is a subset of the superfamily of tetraspan transmembrane protein encoding
genes. It was first identified as a translocation partner with the HMGIC gene in benign lipomas
[35]. The human LHFP/COG6 locus was also identified by GWAS as harboring variants associ-
ated with hippocampal volume [45]. However, prior to this study Lhfp had not been connected
to the regulation of osteoblast function or BMD. Based on our experimental results, we
hypothesize that Lhfp regulates bone mass through a role in cells of the osteoblast lineage. This
does fit with prior work implicating Lhfp in the mesenchymal differentiation of gliosarcoma
[46]. It is possible that Lhfp serves as a “brake” regulating the number of osteogenic precursor
cells in the bone marrow microenvironment as well as their differentiation potential. However,
further work will be required to elucidate its precise molecular role in osteoblasts and bone.
In summary, we have used GWAS in a set of inbred strains to identify an association
impacting femoral BMD on Chr. 3 at 52.5 Mbp. We show using a variety of approaches that
Lhfp is likely responsible for most, if not all, of the effects of this locus. Our results identify
Lhfp as a novel negative regulator of osteoblast function and BMD and increase our under-
standing of the genetics of BMD.
Materials and methods
Ethics statement
The animal protocol for the generation and characterization of Lhfp mutant mice was
approved by the Institutional Care and Use Committee (IACUC) at the University of Virginia.
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Association analysis
The “Ackert” strain set contained BMD data on 32 inbred strains at three time points (6, 12
and 18 months). These data were collected by The Jackson Laboratory Nathan Shock Center
of Excellence in the Basic Biology of Aging. Cohorts of males and female mice of 32 inbred
strains of mice were aged to 6, 12 and 18 months of age. The number of mice per sex and per
strain for each age point ranged from 1 mouse to 9 mice per group, with the majority of groups
containing 6–7 mice. For the 12 month data set, the focus of this paper, the group size ranged
from 3 to 9 mice per strain, per sex. At 6, 12 and 18 months of age, a varity of phenotypes were
measured using a cross sectional study design with the hopes of capturing the main definers of
Healthspan. This study, and the phenotypes available, is described in detail elsewhere [47].
Whole body BMD, sans the head, was measured by Dual X-ray Absorptiometry as previously
described [48]. The complete dataset is available from the Mouse Phenome Database (MPD)
(https://phenome.jax.org/projects/Ackert1). After removing wild-derived strains, and
C57BLKS/J (due to inclusion of this strain producing spurious results) we were left with data
on 26 strains. To identify loci influencing BMD, we used the Efficient Mixed Model Associa-
tion (EMMA) algorithm [23]. For the analysis BMD was rankZ transformed. SNPs were
obtained from strains genotyped on the Mouse Diversity Array (http://churchill-lab.jax.org/
website/MDA) [49]. SNPs with a minor allele frequency< 0.05 were removed, leaving 228,085
SNPs. These SNPs were used to generate a kinship using the ‘emma.kinship’ R script available
in the EMMA R package (available at http://mouse.cs.ucla.edu/emma/) [23]. The emma.
REML.t function of EMMA was used to perform all mapping analyses. The significance of the
maximum association peak was assessed by performing 1,000 permutations of the data. In
each permutation, the minimum p-value was recorded to produce an empirical distribution of
minimum permutation p-values. The quantiles of this distribution were used to assign
adjusted p-values. P-values exceeding a genome-wide significant of P<0.05 were used as
thresholds to identify associated loci. GWAS resulted were visualized using the “qqman” R
package [50]. Replication of the association on Chr. 3@52.5 Mbp was performed using “Tord-
off” and “Naggert” inbred strains sets. These data are available from MPD (https://phenome.
jax.org/projects/Naggert1 and https://phenome.jax.org/projects/Tordoff3). Replication analy-
ses were restricted to Chr. 3 and otherwise performed as described above.
Generating expression profiles for transcripts in the BMD locus
Femora were isolated from an inbred Collaborative Cross strain (CC016/GeniUnc; Jackson
Lab Stock #024684) (N = 3 mice). Marrow was isolated and bone marrow stromal cells
(BMSCs) were differentiated as described below. Total RNA was then isolated from bone and
BMSC-derived osteoblasts using RNeasy Plus Mini Kit (Qiagen). RNA-Seq libraries were con-
structed using TruSeq RNA Library Prep Kit v2 sample prep kits (Illumina). Samples were
sequenced to an average depth of 24.6 million 2 x 75 bp paired-end reads on an Illumina Next-
Seq500 sequencer. Fastq files were aligned to the mouse reference (GRCm38) using HISAT2 v
2.0.5 (https://ccb.jhu.edu/software/hisat2/index.shtml) with a SNP aware reference index (gen-
ome_snp) [51]. Expression levels in Fragments Per Kilobase of transcript per Million mapped
reads (FPKM) were generated using Stringtie [51]. The data are available from GEO
(GSE121887). Microarray profiles for Cog6 and Lhfp in 96 tissues/cell-types were downloaded
from BioGPS (http://biogps.org).
EQTL analyses
The generation of microarray expression data and eQTL analyses on bone from the 96 strains
of the Hybrid Mouse Diversity Panel (HMDP) has been previously described [41,42]. These
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data are available from NCBI Gene Expression Omnibus (GEO) (GSE27483). A t-test was
used to test for differences in Cog6 and Lhfp expression in strains stratified by genotype at
rs3691451 (of the 17 peak BMD SNPs). Liver, brain, muscle and adipose eQTL in the BXH F2
were identified using R/qtl [52]. The expression data is available from GEO (GSE11338,
GSE11065, GSE12798, and GSE12795). The genotypes and expression data are also available
from GeneNetwork (“BH/HB F2 UCLA”, http://www.genenetwork.org/webqtl/main.py).
Network analysis
The generation of a bone co-expression network and characterization of the module 9 (M9) is
described in [42]. We identified genes with the strongest connections to Cog6 and Lhfp based
on Topological Overlap Measures (TOMs), calculated as described in [30]. Network depictions
were constructed using Cytoscape [53]. Gene Ontology (GO) analysis was performed using
the PANTHER database statistical overrepresentation test (http://www.pantherdb.org/) [54].
The analysis was restricted to the “GO biological process complete” annotation data set.
Generation of Lhfp mutant mice
The Lhfp knockout mice used in this study were generated using the CRISPR/Cas9 genome
editing technique. Cas9 mRNA that was injected into C57BL6/N embryos was synthesized
exactly as outlined in [55] while the guide RNA (sgRNA) was generated with some modifica-
tions. Briefly, the 20 nucleotide (nt) sequence that would be used to generate the sgRNA was
chosen using the CRISPR design tool developed by the Zhang lab (crispr.mit.edu). The chosen
sequence and its genome map position is homologous to a region in Exon 2 that is approxi-
mately 300 bp, 3’ of the start codon (the ‘ATG’ is located in Exon 2 of Lhfp) (S1 Table). To gen-
erate the sgRNA that would be used for injections, oligonucleotides of the chosen sequence, as
well as the reverse complement (S1 Table, primer 1 and 2, respectively), were synthesized such
that an additional 4 nts (CTTC and AAAC) were added at the 5’ ends of the oligonucleotides
for cloning purposes. These oligonucleotides were annealed to each other by combining equal
molar amounts, heating to 90˚C for 5 min. and allowing the mixture to passively cool to room
temperature. The annealed oligonucleotides were combined with BbsI digested pX330 plasmid
vector (provided by the Zhang lab through Addgene; https://www.addgene.org/) and T4 DNA
ligase (NEB) and subsequently used to transform Stbl3 competent bacteria (Thermo Fisher)
following the manufacturer’s’ protocols. Plasmid DNAs from selected clones were sequenced
from primer 4 (S1 Table) and DNA that demonstrated accurate sequence and position of the
guide were used for all downstream applications. The DNA template used in the synthesis of
the sgRNA was the product of a PCR using the verified plasmid DNA and primers 3 and 5 (S1
Table). The sgRNA was synthesized via in vitro transcription (IVT) by way of the MAXIscript
T7 kit (Thermo Fisher) following the manufacturer’s protocol. sgRNAs were purified and con-
centrated using the RNeasy Plus Micro kit (Qiagen) following the manufacturer’s protocol.
C57BL/6N female mice (Envigo) were super-ovulated and mated with C57BL/6N males.
The females were sacrificed and the fertilized eggs were isolated from the oviducts. The fertil-
ized eggs were co-injected with the purified Cas9 mRNA (100 ng/μl) and sgRNA (30 ng/μl)
under a Leica inverted microscope equipped with Leitz micromanipulators (Leica Microsys-
tems). Injected eggs were incubated overnight in KSOM-AA medium (Millipore Sigma). Two-
cell stage embryos were implanted on the following day into the oviducts of pseudo pregnant
ICR female mice (Taconic or Envigo). Pups were screened by PCR of tail DNA using primers
6 and 7 with subsequent sequencing of the resultant product from primer 8 (S1 Table).
Two sets of injections (of ~100 eggs each) were performed resulting in 2 mice possessing
mutations from each set of injections (A,B and C,D, respectively; Table 1). All 4 mice
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possessed out of frame bi-allelic deletions ranging from 1–16 bp; progeny from only 3 of the
founders (mice A, B, C, Table 1)) were used in this study. Note that an identical 11bp deletion
was found in two mice from two separate injections. qPCR with primers 9 and 10 (S1 Table)
was used to assess Lhfp expression as outlined in [31].
CFU-F and osteogenic differentiation assays
Isolation [56] and differentiation of mesenchymal stromal cells (MSC) from the bone marrow
of mouse femurs was performed as described for osteoblasts [57] with minor modifications.
Briefly, one or both femurs from a given mouse were aseptically isolated, denuded of soft tissue
and the marrow extracted by removing the proximal end of each bone and centrifuging at
2000 xg for 30 s such that the marrow collects into 25 μl of fetal bovine serum (FBS). Exudates
from a single femur were dispersed, via trituration, in 5ml complete media (MEM-alpha, 10%
FBS, 100U penicillin/100ug Streptomycin per ml, 2 mM glutamine). Cells were manually
counted where upon 4 million were used to seed a 10 cm dish for CFU-F determination and
the remainder were applied to a 60mm dish. Media on the 10 cm dishes was changed on days
2, 4 and 8; on day 14, cells were fixed (NBF), stained (Coomassie, BioRad #161–0436) and the
number of CFU-Fs determined via Image J analysis and the manual counting of colonies.
Media on the 60 mm dishes was changed on day 2 with cells removed via trypsin/EDTA
(Gibco) digestion on day 4. Detached cells were triturated in 5ml complete media, pelleted at
1000 xg for 5 min., re-suspended in 1 ml complete media and counted where upon 150,000
cells were used to seed a well of a 12 well dish. A minimum of 2 wells per sample were obtained
for all samples reported here in. Osteoblast differentiation was initiated 3 days after plating (7
days after bone marrow isolation) by replacing the media with complete media supplemented
with 50 μg/ml ascorbic acid, 10 mM beta-glycerophosphate and 10 nM dexamethasone. Media
was changed every other day for 8 days at which time cells were either used as a source for
RNA (mirVana, Thermo Fisher) or used to determine the amount of hydroxyapatite formed
during differentiation [31]. Briefly, cells were washed with PBS, fixed with neutral buffer for-
malin (NBF) for 15 min. and subsequently stained with 40 mM Alizarin Red (AR), pH 5.6 for
20 min and washed extensively with H20. The amount of AR bound to mineral was quantitated
by Image J analysis of scanned images as well as the 5% Perchloric Acid eluate absorbance at
405 nm.
Measurement of BMD and microarchitecture (microCT)
Femoral BMD was measured ex vivo using a Lunar PIXImus II Mouse Densitometer (GE
Medical Systems Model 51045; Madison, WI, USA). Morphologies of the trabecular bone of
the distal femur and cortical bone of the femoral midshaft were measured using micro-focus
X-ray computed tomography (vivaCT 40, Scanco Medical AG, Bassersdorf, Switzerland) fol-
lowing guidelines for assessment of bone microstructure [58]. Tomographic volumes were
acquired at 55 kV and 145 μA, collecting 2000 projections per rotation at 300 millisecond inte-
gration time. Three-dimensional 16-bit grayscale images were reconstructed using Scanco
Evaluation software, Version 6.5–3. Threshold values were adjusted to best match the silhou-
ette of features of interest in the threshold-subtracted image compared to the grey-scale image.
The resulting threshold for hydroxyapatite-equivalent density was 370 mg/cm3 for compact or
cortical bone and 270 mg/cm3 for the trabecular bone region; these values were applied to sub-
sequent samples. Volumetric analysis was confined to the trabecular region for the distal
femur by manual exclusion of the cortical bone. A 1.03 mm high region of interest was ana-
lyzed beginning at 1 mm proximal to the growth plate. For the cortical bone, a 0.3 mm high
region was analyzed at the mid-diaphysis. Measures analyzing the distal femur trabecular site
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included total volume, bone volume, trabecular bone volume fraction (BV/TV), thickness,
number, connectivity density and structure model index (SMI). Cross-sectional measurements
of the cortical bone included bone volume, total volume, marrow area and polar moment of
inertia.
Statistical analysis of Lhfp mutant data
All statistical analyses were conducted using the R language and environment for statistical
computing [59]. The Lhfp qPCR data was analyzed using a t-test. Data are presented as
means ± 1.5 times the interquartile range. CFU-F and osteogenic differentiation data was ana-
lyzed using the “lsmeans” R package [60]. The data were fit to a linear model including the
effects of genotype and sex. P-values were adjusted using the “tukey” method. Data are pre-
sented as lsmeans ± s.e.m. BMD and microarchitectural bone data were analyzed using
ANOVA with a linear model including the effects of genotype, body weight, and any other
phenotype-specific covariates. Data are presented as means ± 1.5 times the interquartile range.
Human BMD GWAS data
Data from the largest heel BMD GWAS performed to date were downloaded from http://
www.gefos.org/?q=content/data-release-2018 [9]. LocusZoom was used to create a regional
association plot [61]. The GTEx database V7 was queried for colocalizing eQTL(https://
gtexportal.org/home/) [44].
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